Advanced search    

Search: authors:"Taro Yamashita"

14 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication

Honda, Taro Yamashita, Kouki Nio, Tetsuro Shimakami, Ryougo Shimizu, Saki Nakasyo, Kazuhisa Murai, Natsumi Shirasaki, Hikari Okada, Yoshio Sakai & Shuichi KanekoDepartment of Advanced Medical Technology ... Search for Masao Honda in:Nature Research journals • PubMed • Google Scholar Search for Taro Yamashita in:Nature Research journals • PubMed • Google Scholar Search for Kouki Nio in:Nature Research

Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B

, Yasunari Nakamoto. Investigation: Takuto Nosaka, Tatsushi Naito, Katsushi Hiramatsu, Masahiro Ohtani, Tomoyuki Nemoto, Hiroyuki Marusawa, Ning Ma, Yusuke Hiraku, Shosuke Kawanishi, Taro Yamashita, Shuichi

Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus

Kitamura, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko. Resources: Koichiro Matsuda, Taku Sanada, Takeshi Urabe, Katsuhisa Inamura, Takashi

Localized primary amyloidosis of the breast: a case report and review of the literature

Background Primary amyloidosis of the breast is an unusual benign disease that mostly occurs in postmenopausal elderly women. Amyloidosis is the deposition of amorphous protein within tissues. Breast biopsy is necessary to make a definite diagnosis in order to avoid unnecessary surgical methods. Localized primary amyloidosis of the breast has a good prognosis. However, secondary...

Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells

Hepatocellular carcinoma (HCC) is one of the world’s most aggressive diseases and carries a poor prognosis for patients. Recent evidence suggests that HCC is organized by cancer stem cells (CSCs), which are a subset of cells with stem cell-like features. CSCs are considered a pivotal target for the eradication of cancer, and liver CSCs have been investigated using various stem...

Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model

Background We previously demonstrated that hsa-miR-520d-5p can convert cancer cells into induced pluripotent stem cells (iPSCs) or mesenchymal stem cells (MSCs) via a demethylation process and p53 upregulation in vivo. Additionally, we have reported the non-tumorigenic effect of miR-520d-5p on normal human cells, including fibroblasts. Methods We used atelocollagen-conjugated miR...

Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma

Background We investigated the contribution of subsequent therapy for advanced hepatocellular carcinoma refractory or intolerant to sorafenib. Further, we investigated the impact of sorafenib on overall survival using individual data. Methods We reviewed the medical records of patients with advanced hepatocellular carcinoma treated with sorafenib. Survival after sorafenib...

Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib

effects of sorafenib Takeshi Yamada 0 Masato Abei 0 Inaho Danjoh Ryoko Shirota Taro Yamashita Ichinosuke Hyodo 0 Yukio Nakamura 0 Division of Gastroenterology, Faculty of Medicine, University of Tsukuba

Hsa-miR-520d Converts Fibroblasts into CD105+ Populations

designed the experiments; Yoshitaka Ishihara, Satoshi Tsuno, Taro Yamashita, and Yusuke Endo performed the experiments; Satoshi Tsuno and Norimasa Miura analyzed the data; Satoshi Tsuno contributed reagents

Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma

Background The acyclic retinoid, peretinoin, has been shown to be effective for suppressing hepatocellular carcinoma (HCC) recurrence after definitive treatment in a small-scale randomized clinical trial. However, little has been documented about the mechanism by which peretinoin exerts its inhibitory effects against recurrent HCC in humans in vivo. Methods Twelve hepatitis C...

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners

manuscript. Competing Interests: Prof. Osamu Yokosuka received grant support from Mitsubishi Tanabe Pharma. Dr. Taro Yamashita, an academic editor of PLOS ONE, is listed as a co-author of the manuscript. This

Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature

Akihiko Ueda Takayuki Kosaka Satoshi Yamashita En Kimura Taro Yamashita Yasushi Maeda Teruyuki Hirano Makoto Uchino A 56-year-old man noticed discomfort in his left lower limb, followed by convulsion and

Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas

ING2 (inhibitor of growth family, member 2) is a member of the plant homeodomain (PHD)-containing ING family of putative tumor suppressors. As part of mSin3A-HDAC corepressor complexes, ING2 binds to tri-methylated lysine 4 of histone H3 (H3K4me3) to regulate chromatin modification and gene expression. ING2 also functionally interacts with the tumor suppressor protein p53 to...

Comprehensive gene expression profile of human activated Th1- and Th2-polarized cells

In response to antigen stimulation, Th cells differentiate into two types of effector cells, Th1 and Th2. Th1 cells predominantly mediate cellular immunity, whereas Th2 cells induce humoral allergic responses. We have conducted here serial analysis of gene expression (SAGE) in human activated Th1- and Th2-polarized cells from cord blood. SAGE analysis of 64,510 tags (32,219 and...